|
|
|
|
|
|
EndoPAT is the leading medical device for noninvasive endothelial function assessment. It is FDA-cleared, CE-marked and used in preeminent clinical and research institutions, major epidemiological population-based studies (such as Framingham Heart Study), and pharmaceutical clinical phase studies in over 40 countries. Thousands of tests are performed every month. |
|
|
|
|
|
Endothelial Dysfunction The Risk of the Risk Factors |
|
|
For more than a decade, endothelial dysfunction has been recognized by the medical community as the critical junction between risk factors and clinical disease. It is the earliest detectable stage of cardiovascular disease. Furthermore, it is treatable, and unlike the atherosclerotic plaque that it causes, it is even reversible. |
|
|
EndoPAT Major Features and Advantages: |
|
|
EndoPAT Product Overview |
|
- FDA cleared and CE marked
- Reliable and reproducible results
- Noninvasive
- User independent
- Easy to use
- Office-based
- Supports both clinical and research applications
- Contra-lateral arm monitors systemic changes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
